Insulin degludec 100 U/mL for treatment of spontaneous diabetes mellitus in dogs
Abstract Background The advantages of insulin degludec 100 U/mL (IDeg100) in the treatment of diabetes mellitus (DM) include consistent release, predictable glucose‐lowering effect, and minimal day‐to‐day variability. Hypothesis/Objectives To describe the use of IDeg100 in dogs with DM, level of dia...
Saved in:
Main Authors: | Jocelyn Mott, Arnon Gal, Antonio Maria Tardo, Alisa Berg, Riley Claude, Alexis Hoelmer, Mei Lun Mui, Avin Arjoonsingh, Chen Gilor |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Journal of Veterinary Internal Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1111/jvim.17303 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Impact of Insulin Degludec on Glucocorticoid-Induced Hyperglycemia in Patients with Diabetes and COVID-19 Infection
by: Varun Prasanna, et al.
Published: (2024-04-01) -
The rise of weekly insulins: addressing the challenges of type 2 diabetes care in Brazil
by: André Gustavo Daher Vianna, et al.
Published: (2025-01-01) -
Physiological and pathophysiological actions of insulin in the liver
by: Naoto Kubota, et al.
Published: (2025-02-01) -
Novel soybean peptide iglycin ameliorates insulin resistance of high-fat diet fed C57BL/6J mice and differentiated 3T3L1 adipocytes with improvement of insulin signaling and mitochondrial function
by: Yinghuan Wu, et al.
Published: (2022-11-01) -
The hypoglycemic potential of phenolics from functional foods and their mechanisms
by: Oksana Golovinskaia, et al.
Published: (2023-07-01)